KGF suppresses α2β1 integrin function and promotes differentiation of the transient amplifying population in human prostatic epithelium

Journal of Cell Science

Volumn 119, Issue 7, 2006, Pages 1416-1424

  Heer, Rakesh ^a   Collins, Anne T ^b   Robson, Craig N ^a   Shenton, Brian K ^c   Leung, Hing Y ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF YORK   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

1 integrin; Epithelia; KGF; p38; Prostate; Stem cells; Transient amplifying cells

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ACID PHOSPHATASE PROSTATE ISOENZYME; ANDROGEN RECEPTOR; BLOCKING ANTIBODY; CD133 ANTIGEN; CYTOKERATIN 18; FIBROBLAST GROWTH FACTOR RECEPTOR 2; KERATINOCYTE GROWTH FACTOR; METHYLCELLULOSE; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; PROTEIN TYROSINE KINASE; VERY LATE ACTIVATION ANTIGEN 2; 4',6 DIAMIDINO 2 PHENYLINDOLE; BIOLOGICAL MARKER; FLUORESCEIN ISOTHIOCYANATE; FLUORESCENT DYE; INDOLE DERIVATIVE;

ARTICLE; BASAL CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL POPULATION; CONTROLLED STUDY; ENZYME REPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; ORGANOGENESIS; PRIORITY JOURNAL; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; RECEPTOR AFFINITY; REGULATORY MECHANISM; STEM CELL; STROMA CELL; AGED; CONFOCAL MICROSCOPY; CYTOLOGY; DRUG EFFECT; EPITHELIUM CELL; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; MALE; METABOLISM; MIDDLE AGED; PROSTATE; ULTRASTRUCTURE;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELLS, CULTURED; EPITHELIAL CELLS; FIBROBLAST GROWTH FACTOR 7; FLOW CYTOMETRY; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT DYES; GENE EXPRESSION REGULATION; HUMANS; INDOLES; INTEGRIN ALPHA2BETA1; MALE; MICROSCOPY, CONFOCAL; MIDDLE AGED; PROSTATE;

EID: 33646793645     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.02802     Document Type: Article

References (52)

1. Adams, J. C. and Watt, F. M. (1989). Fibronectin inhibits the terminal differentiation of human keratinocytes. Nature 340, 307-309.
2. Alarid, E. T., Rubin, J. S., Young, P., Chedid, M., Ron, D., Aaronson, S. A. and Cunha, G. R. (1994). Keratinocyte growth factor functions in epithelial induction during seminal vesicle development. Proc. Natl. Acad Sci. USA 91, 1074-1078.
3. Arnold, I. and Watt, F. M. (2001). c-Myc activation in transgenic mouse epidermis results in mobilization of stem cells and differentiation of their progeny. Curr. Biol. 11, 558-568.
4. Bonkhoff, H. and Remberger, K. (1996). Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model. Prostate 28, 98-106.
5. Bonkhoff, H., Stein, U. and Remberger, K. (1994a). Multidirectional differentiation in the normal, hyperplastic, and neoplastic human prostate: simultaneous demonstration of cell-specific epithelial markers. Hum. Pathol. 25, 42-46.
6. Bonkhoff, H., Stein, U. and Remberger, K. (1994b). The proliferative function of basal cells in the normal and hyperplastic human prostate. Prostate 24, 114-118.
7. Byrne, R. L., Leung, H. and Neal, D. E. (1996). Peptide growth factors in the prostate as mediators of stromal epithelial interaction. Br J. Urol. 77, 627-633.
8. Collins, A. T. and Maitland, N. J. (2003). The origins of prostate carcinoma. Cancer Topics 11, 1-5.
9. Collins, A. T., Habib, F. K., Maitland, N. J. and Neal, D. E. (2001). Identification and isolation of human prostate epithelial stem cells based on alpha(2)beta(1)-integrin expression. J. Cell Sci. 114, 3865-3872.
10. Culig, Z., Hobisch, A., Cronauer, M. V., Radmayr, C., Trapman, J., Hittmair, A., Bartsch, G. and Klocker, H. (1994). Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor. Cancer Res. 54, 5474-5478.
11. Culig, Z., Hobisch, A., Cronauer, M. V., Radmayr, C., Hittmair, A., Zhang, J., Thurnher, M., Bartsch, G. and Klocker, H. (1996). Regulation of prostatic growth and function by peptide growth factors. Prostate 28, 392-405.
12. Cunha, G. R. (1996). Growth factors as mediators of androgen action during male urogenital development. Prostate Suppl. 6, 22-25.
13. Cunha, G. R. and Young, P. (1991). Inability of Tfm (testicular feminization) epithelial cells to express androgen-dependent seminal vesicle secretory proteins in chimeric tissue recombinants. Endocrinology 128, 3293-3298.
14. Cunha, G. R., Young, P., Higgins, S. J. and Cooke, P. S. (1991). Neonatal seminal vesicle mesenchyme induces a new morphological and functional phenotype in the epithelia of adult ureter and ductus deferens. Development 111, 145-158.
15. Dazard, J. E., Piette, J., Basset-Seguin, N., Blanchard, J. M. and Gandarillas, A. (2000). Switch from p53 to NMM2 as differentiating human keratinocytes lose their proliferative potential and increase in cellular size. Oncogene 19, 3693-3705.
16. Dermer, G. B. (1978). Basal cell proliferation in benign prostatic hyperplasia. Cancer 41, 1857-1862.
17. Donjacour, A. A. and Cunha, G. R. (1995). Induction of prostatic morphology and secretion in urothelium by seminal vesicle mesenchyme. Development 121, 2199-2207.
18. Feldman, B. J. and Feldman, D. (2001). The development of androgen-independent prostate cancer. Nat. Rev. Cancer 1, 34-45.
19. Franco, O. E., Onishi, T., Yamakawa, K., Arima, K., Yanagawa, M., Sugimura, Y. and Kawamura, J. (2003). Mitogen-activated protein kinase pathway is involved in androgen-independent PSA gene expression in LNCaP cells. Prostate 56, 319-325.
20. Giri, D., Ropiquet, F. and Ittmann, M. (1999). Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-I in human prostate cancer. Clin. Cancer Res. 5, 1063-1071.
21. Green, H. (1977). Terminal differentiation of cultured human epidermal cells. Cell 11, 405-416.
22. Hudson, D. L., O'Hare, M., Watt, F. M. and Masters, J. R. (2000). Proliferative heterogencity in the human prostate: evidence for epithelial stem cells. Lab. Invest. 80, 1243-1250.
23. Imamov, 0., Morani, A., Shim, G. J., Omoto, Y., Thulin-Andersson, C., Warner, M. and Gustafsson, J. A. (2004). Estrogen receptor beta regulates epithelial cellular differentiation in the mouse ventral prostate. Proc. Natl. Acad. Sci. USA 101, 9375-9380.
24. Isaacs, J. T. and Coffey, D. S. (1989). Etiology and disease process of benign prostatic hyperplasia. Prostate Suppl. 2, 33-50.
25. Isaacs, W. B. (1984). Structural and functional components in normal and hyperplastic canine prostates. Prog. Clin. Biol. Res. 145, 307-331.
26. Jones, P. H., Harper, S. and Watt, F. M. (1995). Stem cell patterning and fate in human epidermis. Cell 80, 83-93.
27. Kyprianou, N. and Isaacs, J. T. (1988). Activation of programmed cell death in the rat ventral prostate after castration. Endocrinology 122, 552-562.
28. Leone, D. P., Relvas, J. B., Campos, L. S., Hemmi, S., Brakebusch, C., Fassler, R., Ffrench-Constant, C. and Suter, U. (2005). Regulation of neural progenitor proliferation and survival by (beta) 1 integrins. J. Cell Sci. 118, 2589-2599.
29. Levy, L., Broad, S., Diekmann, D., Evans, R. D. and Watt, F. M. (2000). beta1 integrins regulate keratinocyte adhesion and differentiation by distinct mechanisms. Mol. Biol. Cell 11, 453-466.
30. Li, A., Simmons, P. J. and Kaur, P. (1998). Identification and isolation of candidate human keratinocyte stem cells based on cell surface phenotype. Proc. Natl. Acad. Sci. USA 95, 3902-3907.
31. Lin, D. L., Whitney, M. C., Yao, Z. and Keller, E. T. (2001). Interleukin-6 induces androgen responsiveness in prostate cancer cells through upregulation of androgen receptor expression. Clin. Cancer Res. 7, 1773-1781.
32. Liu, A. Y., True, L. D., LaTray, L., Nelson, P. S., Ellis, W. J., Vessella, R. L., Lange, P. H., Hood, L. and van den Engh, G. (1997). Cell-cell interaction in prostate gene regulation and cytodifferentiation. Proc. Natl. Acad. Sci. USA 94, 10705-10710.
33. McKeehan, W. L. (199 1). Growth factor receptors and prostate cell growth. Cancer Surv. 11, 165-175.
34. Mehta, F., Robson, C. N., Neal, D. E. and Leung, H. Y. (2000). Fibroblast growth factor receptor-2 mutation analysis in human prostate cancer. BJU Int. 86, 681-685.
35. Nylander, K., Vojtesek, B., Nenutil, R., Lindgren, B., Roos, G., Zhanxiang, W., Sjostrom, B., Dahlqvist, A. and Coates, P. J. (2002). Differential expression of p63 isoforms in normal tissues and neoplastic cells. J. Pathol. 198, 417-427.
36. Planz, B., Wang, Q., Kirley, S. D., Marberger, M. and McDougal, W. S. (2001). Regulation of keratinocyte growth factor receptor and androgen receptor in epithelial cells of the human prostate. J Urol. 166, 678-683.
37. Prins, G. S., Birch, L. and Greene, G. L. (1991). Androgen receptor localization in different cell types of the adult rat prostate. Endocrinology 129, 3187-3199.
38. Reya, T., Morrison, S. J., Clarke, M. F. and Weissman, I. L. (2001). Stem cells, cancer, and cancer stem cells. Nature 414, 105-111.
39. Richardson, G. D., Robson, C. N., Lang, S. H., Neal, D. E., Maitland, N. J. and Collins, A. T. (2004). CD133, a novel marker for human prostatic epithelial stem cells. J. Cell Sci. 117, 3539-3545.
40. Robinson, E. J., Neal, D. E. and Collins, A. T. (1998). Basal cells are progenitors of luminal cells in primary cultures of differentiating human prostatic epithelium. Prostate 37, 149-160.
41. Schofield, R. (1978). The relationship between the spleen colony-forming cell and the haemopoietic stem cell. Blood Cells 4, 7-25.
42. Spradling, A., Drummond-Barbosa, D. and Kai, T. (2001). Stem cells find their niche. Nature 414, 98-104.
43. Sugimura, Y., Foster, B. A., Hom, Y. K., Lipschutz, J. H., Rubin, J. S., Finch, F. W., Aaronson, S. A., Hayashi, N., Kawamura, J. and Cunha, G. R. (1996). Keratinocyte growth factor (KGF) can replace testosterone in the ductal branching morphogenesis of the rat ventral prostate. Int. J. Dev. Biol. 40, 941-951.
44. Tanaka, Y., Nakayamada, S., Fujimoto, H., Okada, Y., Umehara, H., Kataoka, T. and Minami, Y. (2002). H-Ras/mitogen-acfivated protein kinase pathway inhibits integrinmediated adhesion and induces apoptosis in osteoblasts. J Biol. Chem. 277, 21446-21452.
45. Thomson, A. A., Foster, B. A. and Cunha, G. R. (1997). Analysis of growth factor and receptor mRNA levels during development of the rat seminal vesicle and prostate. Development 124, 2431-2439.
46. Uzgare, A. R. and Isaacs, J. T. (2004). Enhanced redundancy in Akt and mitogenactivated protein kinase-induced survival of malignant versus normal prostate epithelial cells. Cancer Res. 64, 6190-6199.
47. Uzgare, A. R., Kaplan, P. J. and Greenberg, N. M. (2003). Differential expression and/or activation of P38MAPK, erkl/2, and jnk during the initiation and progression of prostate cancer. Prostate 55, 128-139.
48. van Leenders, G., van Balken, B., Aalders, T., Hulsbergen-van de Koo, C., Ruiter, D. and Schalken, J. (2002). Intermediate cells in normal and malignant prostate epithelium express c-MET: implications for prostate cancer invasion. Prostate 51, 98-107.
49. Wang, X. D., Shou, J., Wong, P., French, D. M. and Goo, W. Q. (2004). Notch 1-expressing cells are indispensable for prostatic branching morphogenesis during development and re-growth following castration and androgen replacement. J. Biol. Chem. 279, 24733-24744.
50. Watt, F M., Kobler, M. D., Hotchin, N. A., Nicholson, L. J. and Adams, J. C. (1993). Regulation of keratinocyte terminal differentiation by integrin-extracellular matrix interactions. J. Cell Sci. 106, 175-182.
51. Wernert, N., Seitz, G. and Achtstatter, T. (1987). Immunohistochemical investigation of different cytokeratins and vimentin in the prostate from the fetal period up to adulthood and in prostate carcinoma. Pathol. Res. Pract. 182, 617-626.
52. Zhu, A. J., Haase, I. and Watt, F. M. (1999). Signaling via beta1 integrins and mitogen-activated protein kinase determines human epidermal stem cell fate in vitro. Proc. Natl. Acad. Sci. USA 96, 6728-6733.